Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Weak
Halo Model
MQV
Very Strong
GARP
Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Strong
Telephone
61.3.8833.7800
Address
77-97 Ricketts Road Mt. Waverley, Victoria (VIC) 3149
Description
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. It operates through the following segments: Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. The Diagnostic and Scientific segment is involved in blood bank diagnostics manufacturer, clinical pathology diagnostics distribution, and scientific and research and development laboratory equipment distribution. The Devices segment focuses on ophthalmology and optometry, orthopedics, pain management, infection prevention, and OrthoBiologics. The Capital and Consumables segment offers medical, surgical, and veterinary services. The Service and Technology segment refers to offering biomedical devices to capital equipment, service support and technology management, and service partnership brands. The company was founded in 1994 and is headquartered in Mt. Waverley, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.29 - 0.59
Trade Value (12mth)
AU$115,960.00
1 week
-3.66%
1 month
-24.04%
YTD
-19.39%
1 year
27.42%
All time high
5.11
EPS 3 yr Growth
-63.30%
EBITDA Margin
1.70%
Operating Cashflow
$44m
Free Cash Flow Return
11.50%
ROIC
2.20%
Interest Coverage
3.20
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
1655m
HALO Sector
Healthcare
Next Company Report Date
21-Aug-25
Ex Dividend Date (est.)
18-Sep-23
Next Dividend Pay Date (est.)
06-Oct-23
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
27 March 25 |
Change in substantial holding from WMI/WAM/WAX
×
Change in substantial holding from WMI/WAM/WAX |
21 March 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
20 March 25 |
Appointment of Independent Non-Executive Director
×
Appointment of Independent Non-Executive Director |
12 March 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
11 March 25 |
Transition to Non-Executive Director
×
Transition to Non-Executive Director |
07 March 25 |
S&P DJI Announces March 2025 Quarterly Rebalance
×
S&P DJI Announces March 2025 Quarterly Rebalance |
27 February 25 |
HY25 Appendix 4D and Half Year Report
×
HY25 Appendix 4D and Half Year Report |
27 February 25 |
HY25 Results Release
×
HY25 Results Release |
27 February 25 |
HY25 Investor Presentation
×
HY25 Investor Presentation |
15 January 25 |
Becoming a substantial holder from WAM/WMI/WAX
×
Becoming a substantial holder from WAM/WMI/WAX |
20 December 24 |
New Retail Pharmacy Wholesale Funding
×
New Retail Pharmacy Wholesale Funding |
20 December 24 |
Appointment of Chief Financial Officer
×
Appointment of Chief Financial Officer |
03 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 November 24 |
Notification regarding unquoted securities - PGC
×
Notification regarding unquoted securities - PGC |
27 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
22 November 24 |
Change of Company Secretary
×
Change of Company Secretary |
21 November 24 |
2024 Annual General Meeting Chair Address & Presentation
×
2024 Annual General Meeting Chair Address & Presentation |
21 November 24 |
Results of 2024 Annual General Meeting
×
Results of 2024 Annual General Meeting |
18 October 24 |
2024 Notice of Annual General Meeting
×
2024 Notice of Annual General Meeting |
15 October 24 |
FY24 Annual Report
×
FY24 Annual Report |
30 September 24 |
Resignation of Joint Company Secretary
×
Resignation of Joint Company Secretary |
25 September 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
25 September 24 |
Corporate Governance Statement and Appendix 4G
×
Corporate Governance Statement and Appendix 4G |
25 September 24 |
Audited Financial Results FY24
×
Audited Financial Results FY24 |
03 September 24 |
Resignation of Chief Financial Officer
×
Resignation of Chief Financial Officer |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.